{"id":535468,"date":"2021-09-08T08:04:07","date_gmt":"2021-09-08T12:04:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/"},"modified":"2021-09-08T08:04:07","modified_gmt":"2021-09-08T12:04:07","slug":"catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/","title":{"rendered":"Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Seasoned Biopharmaceutical Executive Adds Substantial Corporate Development Expertise<\/em><br \/>\n        \n      <\/p>\n<p align=\"justify\">SOUTH SAN FRANCISCO, Calif., Sept.  08, 2021  (GLOBE NEWSWIRE) &#8212; Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced the appointment of Jeanne Jew to its Board of Directors.<\/p>\n<p align=\"justify\">&#8220;We are delighted to welcome Jeanne to our Board of Directors. Jeanne\u2019s deep corporate development expertise will be a tremendous asset as we advance our Protease Medicines pipeline,\u201d said\u00a0Nassim Usman, Ph.D., president and chief executive officer of Catalyst.<\/p>\n<p align=\"justify\">Ms. Jew commented, \u201cI look forward to supporting the company\u2019s continued growth and working with the team on its strategic planning and business development initiatives. Catalyst\u2019s compelling and innovative portfolio of protease medicines address areas of significant unmet medical need for patients.\u201d<\/p>\n<p align=\"justify\">Ms. Jew brings more than 25 years of corporate development experience to her role. She has served as the Chief Business Officer of ALX Oncology Holdings, Inc., since August 2020. Ms. Jew also currently serves as a QB3 Executive Mentor to early-stage life science companies. Prior to joining ALX, she served for over a decade as Senior Vice President, Business Development of Paratek Pharmaceuticals, and as Senior Vice President, Business Development for KaloBios Pharmaceuticals where she led corporate development, strategy, and market planning. Ms. Jew was previously Vice President, Corporate and Commercial Development at Onyx Pharmaceuticals and was responsible for executing the company\u2019s co-promotion collaboration. Earlier in her career, Ms. Jew also held business development positions at Coulter Pharmaceutical, Scios, Inc. and Genentech, Inc. Ms. Jew holds a B.A.in Psychology from Wesleyan University and an M.B.A. from Cornell University.<\/p>\n<p align=\"justify\">\n        <strong>About Catalyst Biosciences, the Protease Medicines company<\/strong><br \/>\n        <br \/>Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare disorders of the complement and coagulation systems. Our protease engineering platform has generated two late-stage clinical programs, including MarzAA, a subcutaneously (SQ) administered next-generation engineered coagulation Factor VIIa (FVIIa) for the treatment of episodic bleeding in subjects with rare bleeding disorders. Our complement pipeline includes a preclinical C3-degrader program licensed to Biogen for dry age-related macular degeneration, an improved complement factor I protease for SQ replacement therapy in patients with CFI deficiency and proteases from our ProTUNE\u2122 C3b-C4b degrader and ImmunoTUNE\u2122 C3a-C5a degrader platforms designed to target specific disorders of the complement or inflammatory pathways as well as other complement programs in development.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release contains forward-looking statements that involve substantial risks and uncertainties. Forward-looking statements include, without limitation, statements about the product candidates of\u00a0Catalyst Biosciences, Inc.\u00a0(the \u201cCompany\u201d) and the benefits of its protease engineering platform. Actual results or events could differ materially from the plans, intentions, expectations and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially, including, but not limited to, the risk that clinical trials and pre-clinical studies may be delayed as a result of COVID-19, competitive products and other factors, that clinical trials may not have satisfactory outcomes, that the Company\u2019s complement degraders are not yet in human clinical trials and will require additional manufacturing validation and pre-clinical testing before entering human clinical trials, that the Company may need to raise additional capital, and other risks described in the &#8220;Risk Factors&#8221; section of the Company&#8217;s Annual Report on Form 10-K filed with the\u00a0Securities and Exchange Commission\u00a0(the \u201cSEC\u201d) on March 4, 2021, the Quarterly Report on Form\u00a010-Q filed with the SEC on\u00a0August 5, 2021, and in other filings filed from time to time with the\u00a0SEC. The Company does not assume any obligation to update any forward-looking statements, except as required by law.<\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong>\n      <\/p>\n<p align=\"justify\">Ana Kapor<br \/>Catalyst Biosciences, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GuWZaFgh5FcEfa59tttAuKHqfTRN3LXRth9tD8EvmmasG1w5hdojhCyEY9e0zqf-3bnzuo1TWFSs5NWyU1S4Hk2s6yqHzOK8F0jOYMZ42rp9Yf_0PZvQUquCUBcH3Nr4YQqNSZ0D9t8_ODVIbmtuph4WQJbD4FIN8UzMM2XtXwzCyzj6LLGOFwQaLapT_2mTNPovcaCh-OU-BamwSUoAcmHPDkElEmOYTsDwL-LWo7Yx9RkA-6mcVB15tobGWrPUS0UVqGtoDEHbP8W06C3zoQ==\" rel=\"nofollow noopener\" target=\"_blank\">investors@catbio.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTgzMyM0MzkzNjUxIzIwMjcyNzY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YTk2ODJjMzctOTM5Yi00MGQxLWEyMGEtMGEwZGRjYjQ4Yjc5LTEwMzkyNDk=\/tiny\/Catalyst-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Seasoned Biopharmaceutical Executive Adds Substantial Corporate Development Expertise SOUTH SAN FRANCISCO, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced the appointment of Jeanne Jew to its Board of Directors. &#8220;We are delighted to welcome Jeanne to our Board of Directors. Jeanne\u2019s deep corporate development expertise will be a tremendous asset as we advance our Protease Medicines pipeline,\u201d said\u00a0Nassim Usman, Ph.D., president and chief executive officer of Catalyst. Ms. Jew commented, \u201cI look forward to supporting the company\u2019s continued growth and working with the team on its strategic planning and business development initiatives. Catalyst\u2019s compelling and innovative portfolio of protease medicines address areas of significant unmet medical need for patients.\u201d Ms. Jew brings more than &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535468","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Seasoned Biopharmaceutical Executive Adds Substantial Corporate Development Expertise SOUTH SAN FRANCISCO, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced the appointment of Jeanne Jew to its Board of Directors. &#8220;We are delighted to welcome Jeanne to our Board of Directors. Jeanne\u2019s deep corporate development expertise will be a tremendous asset as we advance our Protease Medicines pipeline,\u201d said\u00a0Nassim Usman, Ph.D., president and chief executive officer of Catalyst. Ms. Jew commented, \u201cI look forward to supporting the company\u2019s continued growth and working with the team on its strategic planning and business development initiatives. Catalyst\u2019s compelling and innovative portfolio of protease medicines address areas of significant unmet medical need for patients.\u201d Ms. Jew brings more than &hellip; Continue reading &quot;Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-08T12:04:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTgzMyM0MzkzNjUxIzIwMjcyNzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors\",\"datePublished\":\"2021-09-08T12:04:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\\\/\"},\"wordCount\":620,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTgzMyM0MzkzNjUxIzIwMjcyNzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\\\/\",\"name\":\"Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTgzMyM0MzkzNjUxIzIwMjcyNzY=\",\"datePublished\":\"2021-09-08T12:04:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTgzMyM0MzkzNjUxIzIwMjcyNzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTgzMyM0MzkzNjUxIzIwMjcyNzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors - Market Newsdesk","og_description":"Seasoned Biopharmaceutical Executive Adds Substantial Corporate Development Expertise SOUTH SAN FRANCISCO, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced the appointment of Jeanne Jew to its Board of Directors. &#8220;We are delighted to welcome Jeanne to our Board of Directors. Jeanne\u2019s deep corporate development expertise will be a tremendous asset as we advance our Protease Medicines pipeline,\u201d said\u00a0Nassim Usman, Ph.D., president and chief executive officer of Catalyst. Ms. Jew commented, \u201cI look forward to supporting the company\u2019s continued growth and working with the team on its strategic planning and business development initiatives. Catalyst\u2019s compelling and innovative portfolio of protease medicines address areas of significant unmet medical need for patients.\u201d Ms. Jew brings more than &hellip; Continue reading \"Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-08T12:04:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTgzMyM0MzkzNjUxIzIwMjcyNzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors","datePublished":"2021-09-08T12:04:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/"},"wordCount":620,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTgzMyM0MzkzNjUxIzIwMjcyNzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/","name":"Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTgzMyM0MzkzNjUxIzIwMjcyNzY=","datePublished":"2021-09-08T12:04:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTgzMyM0MzkzNjUxIzIwMjcyNzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTgzMyM0MzkzNjUxIzIwMjcyNzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-appointment-of-jeanne-jew-to-its-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535468","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535468"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535468\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}